Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Entergy
ETR
$53.1B
| $19.3M | 0.01% |
476,552
+261,348
| +121% | +$10.8M |
|
|
CMTA
827
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $19.3M | 0.01% |
1,731,192
-15,104
| -0.9% | -$159K |
|
|
WBA
828
DELISTED
Walgreens Boots Alliance
WBA
| $19.2M | 0.01% |
263,702
-1,577
| -0.6% | -$107K |
|
829
Herbalife
HLF
$1.26B
| $19.2M | 0.01% |
351,398
+177,690
| +102% | +$9.82M |
|
830
BorgWarner
BWA
$13.1B
| $19.1M | 0.01% |
506,392
-437,659
| -46% | -$17.2M |
|
831
Public Storage
PSA
$60.5B
| $18.6M | 0.01% |
92,444
-47,429
| -34% | -$10.2M |
|
832
UMB Financial
UMBF
$10.7B
| $18.6M | 0.01% |
262,893
+20
| +0% | +$1.5K |
|
833
Rayonier
RYN
$6.52B
| $18.3M | 0.01% |
596,790
+227,716
| +62% | +$7.29M |
|
834
FirstEnergy
FE
$28.5B
| $18.2M | 0.01% |
490,649
+220,262
| +81% | +$8.05M |
|
835
Albemarle
ALB
$13.7B
| $18.2M | 0.01% |
182,765
-280,316
| -61% | -$27.1M |
|
|
ADMS
836
DELISTED
Adamas Pharmaceuticals
ADMS
| $18.2M | 0.01% |
907,415
-9,571
| -1% | -$225K |
|
837
Targa Resources
TRGP
$57.4B
| $18.2M | 0.01% |
322,499
+116,460
| +57% | +$6.21M |
|
838
Movado Group
MOV
$835M
| $17.8M | 0.01% |
423,778
-5,509
| -1% | -$258K |
|
839
Lazard
LAZ
$4.23B
| $17.7M | 0.01% |
368,700
-7,148
| -2% | -$355K |
|
840
Paychex
PAYX
$41.1B
| $17.5M | 0.01% |
238,198
+111,117
| +87% | +$7.99M |
|
841
Essex Property Trust
ESS
$18.7B
| $17.5M | 0.01% |
70,795
-28,809
| -29% | -$6.94M |
|
842
Rogers Communications
RCI
$17.7B
| $17.4M | 0.01% |
337,629
-199,837
| -37% | -$10.2M |
|
843
Yum China
YUMC
$15.3B
| $17M | 0.01% |
484,980
-345,553
| -42% | -$12.3M |
|
|
CBIO
844
Crescent Biopharma
CBIO
$626M
| $16.8M | 0.01% |
11,695
-150
| -1% | -$227K |
|
845
Masco
MAS
$16.4B
| $16.7M | 0.01% |
456,282
-1,366,894
| -75% | -$52.6M |
|
846
Post Holdings
POST
$4.14B
| $16.7M | 0.01% |
260,202
+50,316
| +24% | +$3.09M |
|
847
Bank of Montreal
BMO
$125B
| $16.5M | 0.01% |
199,661
+4,629
| +2% | +$372K |
|
|
SWCH
848
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $16.4M | 0.01% |
1,516,979
-647,323
| -30% | -$7.79M |
|
849
Mondelez International
MDLZ
$77.9B
| $16.3M | 0.01% |
379,673
+1,797
| +0.5% | +$76.7K |
|
|
EVHC
850
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $16M | 0.01% |
349,400
+194,200
| +125% | +$8.72M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.